Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

FRA:ABO - Deutsche Boerse Ag - DE000A1EWXA4 - Common Stock - Currency: EUR

1.41  -0.02 (-1.4%)

Fundamental Rating

3

Overall ABO gets a fundamental rating of 3 out of 10. We evaluated ABO against 22 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of ABO have multiple concerns. ABO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ABO has reported negative net income.
In the past year ABO had a positive cash flow from operations.
ABO had positive earnings in 4 of the past 5 years.
ABO had a positive operating cash flow in each of the past 5 years.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

The Return On Assets of ABO (-0.37%) is worse than 68.18% of its industry peers.
ABO has a Return On Equity of -0.92%. This is in the lower half of the industry: ABO underperforms 68.18% of its industry peers.
The Return On Invested Capital of ABO (0.76%) is worse than 72.73% of its industry peers.
ABO had an Average Return On Invested Capital over the past 3 years of 2.96%. This is below the industry average of 5.31%.
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROIC 0.76%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Operating Margin, with a value of 12.83%, ABO is in line with its industry, outperforming 45.45% of the companies in the same industry.
In the last couple of years the Operating Margin of ABO has declined.
ABO's Gross Margin of 99.48% is amongst the best of the industry. ABO outperforms 100.00% of its industry peers.
ABO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.83%
PM (TTM) N/A
GM 99.48%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ABO has about the same amount of shares outstanding.
ABO has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ABO is higher compared to a year ago.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.53. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
ABO's Altman-Z score of 0.53 is on the low side compared to the rest of the industry. ABO is outperformed by 72.73% of its industry peers.
ABO has a debt to FCF ratio of 12.18. This is a negative value and a sign of low solvency as ABO would need 12.18 years to pay back of all of its debts.
ABO has a better Debt to FCF ratio (12.18) than 86.36% of its industry peers.
A Debt/Equity ratio of 1.15 is on the high side and indicates that ABO has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.15, ABO is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.18
Altman-Z 0.53
ROIC/WACC0.22
WACC3.5%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ABO has a Current Ratio of 0.82. This is a bad value and indicates that ABO is not financially healthy enough and could expect problems in meeting its short term obligations.
ABO has a Current ratio of 0.82. This is amonst the worse of the industry: ABO underperforms 81.82% of its industry peers.
A Quick Ratio of 0.82 indicates that ABO may have some problems paying its short term obligations.
ABO has a Quick ratio of 0.82. This is amonst the worse of the industry: ABO underperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.42%.
The Revenue for ABO has decreased by -19.53% in the past year. This is quite bad
Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 1.75% on average per year.
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.89%
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%

3.2 Future

ABO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -35.51% yearly.
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 12.98% on average per year.
EPS Next Y13.1%
EPS Next 2Y9.87%
EPS Next 3Y-35.51%
EPS Next 5YN/A
Revenue Next Year19.03%
Revenue Next 2Y16.31%
Revenue Next 3Y12.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABO. In the last year negative earnings were reported.
Also next year ABO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABO is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABO indicates a rather cheap valuation: ABO is cheaper than 90.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.34
EV/EBITDA 14.88
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ABO's earnings are expected to decrease with -35.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.87%
EPS Next 3Y-35.51%

4

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 3.85%.
ABO's Dividend Yield is rather good when compared to the industry average which is at 3.51. ABO pays more dividend than 81.82% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, ABO pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.85%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y9.87%
EPS Next 3Y-35.51%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

CLEARVISE AG

FRA:ABO (7/17/2025, 7:00:00 PM)

1.41

-0.02 (-1.4%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)05-09 2025-05-09
Earnings (Next)08-15 2025-08-15
Inst Owners5.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap106.26M
Analysts85
Price Target3.2 (126.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.85%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.03
P/FCF 6.34
P/OCF 6.34
P/B 0.67
P/tB 0.67
EV/EBITDA 14.88
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.22
FCFY15.77%
OCF(TTM)0.22
OCFY15.77%
SpS0.47
BVpS2.12
TBVpS2.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROCE 1.25%
ROIC 0.76%
ROICexc 0.77%
ROICexgc 0.77%
OM 12.83%
PM (TTM) N/A
GM 99.48%
FCFM 47.74%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.96%
ROIC(5y)2.52%
ROICexc(3y)3.53%
ROICexc(5y)2.94%
ROICexgc(3y)3.56%
ROICexgc(5y)2.99%
ROCE(3y)4.91%
ROCE(5y)4.17%
ROICexcg growth 3Y9.45%
ROICexcg growth 5Y-12.72%
ROICexc growth 3Y10.45%
ROICexc growth 5Y-12.08%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.18
Debt/EBITDA 8.92
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 81.64%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.53
F-Score3
WACC3.5%
ROIC/WACC0.22
Cap/Depr(3y)124.13%
Cap/Depr(5y)91.46%
Cap/Sales(3y)46.11%
Cap/Sales(5y)37.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.89%
EPS Next Y13.1%
EPS Next 2Y9.87%
EPS Next 3Y-35.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%
Revenue Next Year19.03%
Revenue Next 2Y16.31%
Revenue Next 3Y12.98%
Revenue Next 5YN/A
EBIT growth 1Y-60.34%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year444.54%
EBIT Next 3Y84.01%
EBIT Next 5YN/A
FCF growth 1Y-220.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.62%
OCF growth 3Y-7.16%
OCF growth 5Y-8.38%